Preclinical evaluation of anti-VEGFR2 monoclonal antibody ramucirumab labelled with zirconium-89 for tumour imaging
Preclinical evaluation of anti-VEGFR2 monoclonal antibody ramucirumab labelled with zirconium-89 for tumour imaging.
Journal of Labelled Compounds & Radiopharmaceuticals.
2021,
64(7),
262-270,
ISSN: 0362-4803,
PMID: 33818828,